Clinical Trial Update: Cannabinoids in Bipolar Affective Disorder [NA]

View source ↗

Summary

A clinical trial evaluating cannabinoids for bipolar affective disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Affective Disorder

Drugs mentioned

• Cannabinoids (cannabinoids)

Snippet

Sponsor: University of British Columbia | Conditions: Bipolar Affective Disorder | NA | Status: WITHDRAWN